Discovery Projects - Grant ID: DP150103953

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/DP150103953

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Enabling aerosol delivery of phages to defeat antibiotic-resistant bacteria. This project aims to explore the use of bacteriophages towards producing a safe, natural, and highly effective alternative to traditional antibiotics. Respiratory infections caused by multidrug-resistant Gram-negative bacteria are a major health problem worldwide, and cost Australia over $150 million annually. Some 5,000 Australians die each year from antibiotic resistant infections. The project aims to produce efficacious and stable formulations of bacteriophages for easy delivery by inhalation as aerosols with a long shelf-life, making them a commercially viable product. The expected research outcome can lead to an economic and efficient technology to produce phage powders for novel treatment strategies of infections by inhalation.

Funded Activity Details

Start Date: 01-02-2015

End Date: 31-05-2018

Funding Scheme: Discovery Projects

Funding Amount: $546,522.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Pharmacology and Pharmaceutical Sciences | Pharmaceutical Sciences | Respiratory Diseases | Powder and Particle Technology |

ANZSRC Socio-Economic Objective (SEO)

Human Pharmaceutical Treatments (e.g. Antibiotics) | Infectious Diseases | Expanding Knowledge in Technology

Other Keywords

Expanding Knowledge in Technology | Human Pharmaceutical Treatments (e.g. Antibiotics) | Infectious Diseases | Pharmaceutical Sciences | Pharmacology and Pharmaceutical Sciences | Powder and Particle Technology | Respiratory Diseases

Related Links